Why Mounjaro isn’t subsidized
7:06–7:49 · 43s
Norman and Priya break down Eli Lilly walking away from PBS negotiations over tirzepatide pricing, setting context for access and equity in diabetes care.
7:06–7:49 · 43s
Norman and Priya break down Eli Lilly walking away from PBS negotiations over tirzepatide pricing, setting context for access and equity in diabetes care.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.